| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.02 |
| 52 Week High | CN¥9.72 |
| 52 Week Low | CN¥3.67 |
| Beta | -0.29 |
| 1 Month Change | 1.35% |
| 3 Month Change | -13.75% |
| 1 Year Change | -12.63% |
| 3 Year Change | 34.68% |
| 5 Year Change | 9.45% |
| Change since IPO | -23.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2693 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.1% | 0.7% | 0.9% |
| 1Y | -12.6% | -14.7% | -16.5% |
Rentabilidad frente al sector: 002693 superó al sector CN Pharmaceuticals , que obtuvo un rendimiento del -14.7% el año pasado.
Rentabilidad vs. Mercado: 002693 superó al mercado CN, que obtuvo un rendimiento del -14.9% el año pasado.
Price Volatility
| 2693 volatility | |
|---|---|
| 2693 Average Weekly Movement | 9.8% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 11.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Precio estable de las acciones: 002693ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 002693 (10%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 414 | Jianming Li | https://www.shuangchengmed.com |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. investiga, desarrolla, fabrica y comercializa medicamentos peptídicos sintetizados e ingredientes farmacéuticos activos en todo el mundo. Ofrece somatostatina, timosina, clorhidrato de clindamicina, timopentina, L-carnitina, hidrobromuro de uranina, inosina, ciclofosfina adenosina, motidina, escopolamina y ferulato sódico para inyectables, así como vitamina B6. La empresa se fundó en 2000 y tiene su sede en Haikou (República Popular China).
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Fundamentals Summary
| 2693 fundamental statistics | |
|---|---|
| Market cap | CN¥2.51b |
| Earnings (TTM) | CN¥11.01m |
| Revenue (TTM) | CN¥259.14m |
227.8x
P/E Ratio9.7x
P/S RatioIs 2693 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2693 income statement (TTM) | |
|---|---|
| Revenue | CN¥259.14m |
| Cost of Revenue | CN¥83.79m |
| Gross Profit | CN¥175.34m |
| Other Expenses | CN¥164.33m |
| Earnings | CN¥11.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.026 |
| Gross Margin | 67.66% |
| Net Profit Margin | 4.25% |
| Debt/Equity Ratio | 28.8% |
How did 2693 perform over the long term?
See historical performance and comparison